Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Outlook and Growth Opportunities 2025

Summary

According to APO Research, the global Non-invasive Prenatal Paternity Testing(NIPPT) market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Non-invasive Prenatal Paternity Testing(NIPPT) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.

The Asia-Pacific market for Non-invasive Prenatal Paternity Testing(NIPPT) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Non-invasive Prenatal Paternity Testing(NIPPT) market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.

The Europe market for Non-invasive Prenatal Paternity Testing(NIPPT) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Non-invasive Prenatal Paternity Testing(NIPPT) market include BGI Genomics, Ultrasound Plus, Roche company, PrenatalGeneticslab, Natera, LabCorp, International Biosciences, Illumina and Express Diagnostic Center (EDC), etc. In 2024, the top three vendors accounted for approximately % of the market revenue.

This report presents an overview of global market for Non-invasive Prenatal Paternity Testing(NIPPT), revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Non-invasive Prenatal Paternity Testing(NIPPT), also provides the value of main regions and countries. Of the upcoming market potential for Non-invasive Prenatal Paternity Testing(NIPPT), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non-invasive Prenatal Paternity Testing(NIPPT) revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global Non-invasive Prenatal Paternity Testing(NIPPT) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Non-invasive Prenatal Paternity Testing(NIPPT) company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Non-invasive Prenatal Paternity Testing(NIPPT) Segment by Company

BGI Genomics
Ultrasound Plus
Roche company
PrenatalGeneticslab
Natera
LabCorp
International Biosciences
Illumina
Express Diagnostic Center (EDC)
EasyDNA
DDC
Axis DNA Labs
AlphaBiolabs
AffinityDNA
Acecgt Group
Non-invasive Prenatal Paternity Testing(NIPPT) Segment by Type

Reagents
Service
Non-invasive Prenatal Paternity Testing(NIPPT) Segment by Application

Non-legal Paternity Test
Legal Paternity Test
Non-invasive Prenatal Paternity Testing(NIPPT) Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global Non-invasive Prenatal Paternity Testing(NIPPT) status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Non-invasive Prenatal Paternity Testing(NIPPT) key companies, revenue, market share, and recent developments.
3. To split the Non-invasive Prenatal Paternity Testing(NIPPT) breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Non-invasive Prenatal Paternity Testing(NIPPT) market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Non-invasive Prenatal Paternity Testing(NIPPT) significant trends, drivers, influence factors in global and regions.
6. To analyze Non-invasive Prenatal Paternity Testing(NIPPT) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-invasive Prenatal Paternity Testing(NIPPT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non-invasive Prenatal Paternity Testing(NIPPT) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-invasive Prenatal Paternity Testing(NIPPT).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

1: Introduces the report scope of the report, global total market size.
2: Analysis key trends, drivers, challenges, and opportunities within the global Non-invasive Prenatal Paternity Testing(NIPPT) industry.
3: Detailed analysis of Non-invasive Prenatal Paternity Testing(NIPPT) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
6: Sales value of Non-invasive Prenatal Paternity Testing(NIPPT) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
7: Sales value of Non-invasive Prenatal Paternity Testing(NIPPT) in country level. It provides sigmate data by type, and by application for each country/region.
8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
9: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Size, 2020 VS 2024 VS 2031
1.3 Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Size (2020-2031)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Non-invasive Prenatal Paternity Testing(NIPPT) Market Dynamics
2.1 Non-invasive Prenatal Paternity Testing(NIPPT) Industry Trends
2.2 Non-invasive Prenatal Paternity Testing(NIPPT) Industry Drivers
2.3 Non-invasive Prenatal Paternity Testing(NIPPT) Industry Opportunities and Challenges
2.4 Non-invasive Prenatal Paternity Testing(NIPPT) Industry Restraints
3 Non-invasive Prenatal Paternity Testing(NIPPT) Market by Company
3.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Company Revenue Ranking in 2024
3.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Company (2020-2025)
3.3 Global Non-invasive Prenatal Paternity Testing(NIPPT) Company Ranking (2023-2025)
3.4 Global Non-invasive Prenatal Paternity Testing(NIPPT) Company Manufacturing Base and Headquarters
3.5 Global Non-invasive Prenatal Paternity Testing(NIPPT) Company Product Type and Application
3.6 Global Non-invasive Prenatal Paternity Testing(NIPPT) Company Establishment Date
3.7 Market Competitive Analysis
3.7.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Concentration Ratio (CR5 and HHI)
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.7.3 2024 Non-invasive Prenatal Paternity Testing(NIPPT) Tier 1, Tier 2, and Tier 3 Companies
3.8 Mergers and Acquisitions Expansion
4 Non-invasive Prenatal Paternity Testing(NIPPT) Market by Type
4.1 Non-invasive Prenatal Paternity Testing(NIPPT) Type Introduction
4.1.1 Reagents
4.1.2 Service
4.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Type
4.2.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Type (2020 VS 2024 VS 2031)
4.2.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Type (2020-2031)
4.2.3 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type (2020-2031)
5 Non-invasive Prenatal Paternity Testing(NIPPT) Market by Application
5.1 Non-invasive Prenatal Paternity Testing(NIPPT) Application Introduction
5.1.1 Non-legal Paternity Test
5.1.2 Legal Paternity Test
5.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Application
5.2.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Application (2020 VS 2024 VS 2031)
5.2.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Application (2020-2031)
5.2.3 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application (2020-2031)
6 Non-invasive Prenatal Paternity Testing(NIPPT) Regional Value Analysis
6.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Region: 2020 VS 2024 VS 2031
6.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Region (2020-2031)
6.2.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Region: 2020-2025
6.2.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Region (2026-2031)
6.3 North America
6.3.1 North America Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value (2020-2031)
6.3.2 North America Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Country, 2024 VS 2031
6.4 Europe
6.4.1 Europe Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value (2020-2031)
6.4.2 Europe Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Country, 2024 VS 2031
6.5 Asia-Pacific
6.5.1 Asia-Pacific Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value (2020-2031)
6.5.2 Asia-Pacific Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Country, 2024 VS 2031
6.6 South America
6.6.1 South America Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value (2020-2031)
6.6.2 South America Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Country, 2024 VS 2031
6.7 Middle East & Africa
6.7.1 Middle East & Africa Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value (2020-2031)
6.7.2 Middle East & Africa Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Country, 2024 VS 2031
7 Non-invasive Prenatal Paternity Testing(NIPPT) Country-level Value Analysis
7.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Country: 2020 VS 2024 VS 2031
7.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Country (2020-2031)
7.2.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Country (2020-2025)
7.2.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Country (2026-2031)
7.3 USA
7.3.1 USA Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2020-2031)
7.3.2 USA Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2024 VS 2031
7.3.3 USA Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2024 VS 2031
7.4 Canada
7.4.1 Canada Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2020-2031)
7.4.2 Canada Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2024 VS 2031
7.4.3 Canada Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2024 VS 2031
7.5 Mexico
7.5.1 Mexico Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2020-2031)
7.5.2 Mexico Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2024 VS 2031
7.5.3 Mexico Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2024 VS 2031
7.6 Germany
7.6.1 Germany Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2020-2031)
7.6.2 Germany Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2024 VS 2031
7.6.3 Germany Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2024 VS 2031
7.7 France
7.7.1 France Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2020-2031)
7.7.2 France Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2024 VS 2031
7.7.3 France Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2024 VS 2031
7.8 U.K.
7.8.1 U.K. Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2020-2031)
7.8.2 U.K. Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2024 VS 2031
7.8.3 U.K. Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2024 VS 2031
7.9 Italy
7.9.1 Italy Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2020-2031)
7.9.2 Italy Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2024 VS 2031
7.9.3 Italy Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2024 VS 2031
7.10 Spain
7.10.1 Spain Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2020-2031)
7.10.2 Spain Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2024 VS 2031
7.10.3 Spain Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2024 VS 2031
7.11 Russia
7.11.1 Russia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2020-2031)
7.11.2 Russia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2024 VS 2031
7.11.3 Russia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2024 VS 2031
7.12 Netherlands
7.12.1 Netherlands Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2020-2031)
7.12.2 Netherlands Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2024 VS 2031
7.12.3 Netherlands Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2024 VS 2031
7.13 Nordic Countries
7.13.1 Nordic Countries Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2020-2031)
7.13.2 Nordic Countries Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2024 VS 2031
7.13.3 Nordic Countries Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2024 VS 2031
7.14 China
7.14.1 China Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2020-2031)
7.14.2 China Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2024 VS 2031
7.14.3 China Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2024 VS 2031
7.15 Japan
7.15.1 Japan Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2020-2031)
7.15.2 Japan Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2024 VS 2031
7.15.3 Japan Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2024 VS 2031
7.16 South Korea
7.16.1 South Korea Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2020-2031)
7.16.2 South Korea Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2024 VS 2031
7.16.3 South Korea Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2024 VS 2031
7.17 India
7.17.1 India Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2020-2031)
7.17.2 India Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2024 VS 2031
7.17.3 India Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2024 VS 2031
7.18 Australia
7.18.1 Australia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2020-2031)
7.18.2 Australia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2024 VS 2031
7.18.3 Australia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2024 VS 2031
7.19 Southeast Asia
7.19.1 Southeast Asia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2020-2031)
7.19.2 Southeast Asia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2024 VS 2031
7.19.3 Southeast Asia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2024 VS 2031
7.20 Brazil
7.20.1 Brazil Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2020-2031)
7.20.2 Brazil Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2024 VS 2031
7.20.3 Brazil Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2024 VS 2031
7.21 Argentina
7.21.1 Argentina Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2020-2031)
7.21.2 Argentina Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2024 VS 2031
7.21.3 Argentina Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2024 VS 2031
7.22 Chile
7.22.1 Chile Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2020-2031)
7.22.2 Chile Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2024 VS 2031
7.22.3 Chile Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2024 VS 2031
7.23 Colombia
7.23.1 Colombia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2020-2031)
7.23.2 Colombia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2024 VS 2031
7.23.3 Colombia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2024 VS 2031
7.24 Peru
7.24.1 Peru Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2020-2031)
7.24.2 Peru Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2024 VS 2031
7.24.3 Peru Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2024 VS 2031
7.25 Saudi Arabia
7.25.1 Saudi Arabia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2020-2031)
7.25.2 Saudi Arabia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2024 VS 2031
7.25.3 Saudi Arabia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2024 VS 2031
7.26 Israel
7.26.1 Israel Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2020-2031)
7.26.2 Israel Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2024 VS 2031
7.26.3 Israel Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2024 VS 2031
7.27 UAE
7.27.1 UAE Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2020-2031)
7.27.2 UAE Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2024 VS 2031
7.27.3 UAE Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2024 VS 2031
7.28 Turkey
7.28.1 Turkey Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2020-2031)
7.28.2 Turkey Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2024 VS 2031
7.28.3 Turkey Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2024 VS 2031
7.29 Iran
7.29.1 Iran Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2020-2031)
7.29.2 Iran Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2024 VS 2031
7.29.3 Iran Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2024 VS 2031
7.30 Egypt
7.30.1 Egypt Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2020-2031)
7.30.2 Egypt Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2024 VS 2031
7.30.3 Egypt Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 BGI Genomics
8.1.1 BGI Genomics Comapny Information
8.1.2 BGI Genomics Business Overview
8.1.3 BGI Genomics Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
8.1.4 BGI Genomics Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
8.1.5 BGI Genomics Recent Developments
8.2 Ultrasound Plus
8.2.1 Ultrasound Plus Comapny Information
8.2.2 Ultrasound Plus Business Overview
8.2.3 Ultrasound Plus Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
8.2.4 Ultrasound Plus Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
8.2.5 Ultrasound Plus Recent Developments
8.3 Roche company
8.3.1 Roche company Comapny Information
8.3.2 Roche company Business Overview
8.3.3 Roche company Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
8.3.4 Roche company Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
8.3.5 Roche company Recent Developments
8.4 PrenatalGeneticslab
8.4.1 PrenatalGeneticslab Comapny Information
8.4.2 PrenatalGeneticslab Business Overview
8.4.3 PrenatalGeneticslab Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
8.4.4 PrenatalGeneticslab Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
8.4.5 PrenatalGeneticslab Recent Developments
8.5 Natera
8.5.1 Natera Comapny Information
8.5.2 Natera Business Overview
8.5.3 Natera Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
8.5.4 Natera Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
8.5.5 Natera Recent Developments
8.6 LabCorp
8.6.1 LabCorp Comapny Information
8.6.2 LabCorp Business Overview
8.6.3 LabCorp Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
8.6.4 LabCorp Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
8.6.5 LabCorp Recent Developments
8.7 International Biosciences
8.7.1 International Biosciences Comapny Information
8.7.2 International Biosciences Business Overview
8.7.3 International Biosciences Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
8.7.4 International Biosciences Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
8.7.5 International Biosciences Recent Developments
8.8 Illumina
8.8.1 Illumina Comapny Information
8.8.2 Illumina Business Overview
8.8.3 Illumina Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
8.8.4 Illumina Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
8.8.5 Illumina Recent Developments
8.9 Express Diagnostic Center (EDC)
8.9.1 Express Diagnostic Center (EDC) Comapny Information
8.9.2 Express Diagnostic Center (EDC) Business Overview
8.9.3 Express Diagnostic Center (EDC) Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
8.9.4 Express Diagnostic Center (EDC) Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
8.9.5 Express Diagnostic Center (EDC) Recent Developments
8.10 EasyDNA
8.10.1 EasyDNA Comapny Information
8.10.2 EasyDNA Business Overview
8.10.3 EasyDNA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
8.10.4 EasyDNA Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
8.10.5 EasyDNA Recent Developments
8.11 DDC
8.11.1 DDC Comapny Information
8.11.2 DDC Business Overview
8.11.3 DDC Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
8.11.4 DDC Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
8.11.5 DDC Recent Developments
8.12 Axis DNA Labs
8.12.1 Axis DNA Labs Comapny Information
8.12.2 Axis DNA Labs Business Overview
8.12.3 Axis DNA Labs Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
8.12.4 Axis DNA Labs Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
8.12.5 Axis DNA Labs Recent Developments
8.13 AlphaBiolabs
8.13.1 AlphaBiolabs Comapny Information
8.13.2 AlphaBiolabs Business Overview
8.13.3 AlphaBiolabs Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
8.13.4 AlphaBiolabs Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
8.13.5 AlphaBiolabs Recent Developments
8.14 AffinityDNA
8.14.1 AffinityDNA Comapny Information
8.14.2 AffinityDNA Business Overview
8.14.3 AffinityDNA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
8.14.4 AffinityDNA Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
8.14.5 AffinityDNA Recent Developments
8.15 Acecgt Group
8.15.1 Acecgt Group Comapny Information
8.15.2 Acecgt Group Business Overview
8.15.3 Acecgt Group Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
8.15.4 Acecgt Group Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
8.15.5 Acecgt Group Recent Developments
9 Concluding Insights
10 Appendix
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings